Italian Innovation Reaches the Moon: Roboze's 3D Printing Revolution

The Italy-based advanced manufacturing firm Roboze has positioned itself at the forefront of a technological race to enable lunar production capabilities, while simultaneously preparing to disrupt the medical prosthetics market—two ventures that could reshape how critical components are made both on Earth and in space.

Why This Matters

• Space ambitions: Roboze is collaborating with the European Space Agency (ESA) on potential lunar missions, aiming to deploy 3D printing technology on the Moon that uses only local materials.

• Medical breakthrough: The company plans to launch biocompatible polymer prosthetics for human implantation within two years of its announcement, with testing already underway.

• Strategic expansion: A new California headquarters opened in early 2026 to serve Lockheed Martin, Northrop Grumman, and SpaceX, reinforcing ties with the U.S. defense and aerospace complex.

• Homegrown innovation: Founded 18 years ago by a 17-year-old from Bari, the firm now holds 15 global patents and operates across six locations on three continents.

From a Bari Workshop to Orbit

Alessio Lorusso, now CEO of Roboze, began experimenting with 3D printing as a teenager in his father's mechanical workshop in Bari. Frustrated by the industry's fixation on prototyping rather than production, he engineered a fundamentally different approach: precision-driven printers that move with the accuracy of Swiss watchmaking, capable of fabricating functional components rather than mere models.

That insight—transforming additive manufacturing from a design tool into a production-ready platform—became the company's DNA. Today, Roboze employs 140 people across facilities in Italy, Texas, California, Abu Dhabi, and Poland, all linked by a proprietary cloud operating system called Tesserat that monitors roughly 400 machines worldwide in real time.

The Italian firm has carved out a niche in super-polymer and composite materials engineered to withstand extreme environments: oil rigs in Alaska, rocket engines, helicopter rotors, and high-speed rail systems. Components made with advanced polymers can endure temperatures, corrosive chemicals, and mechanical stresses that would destroy conventional plastics or even some metals—all while delivering weight savings crucial for aerospace applications.

What This Means for Italy's Industrial Position

Roboze's trajectory underscores a broader strategic pivot: the pursuit of industrial sovereignty through localized, on-demand manufacturing. By replacing reliance on traditional supply chains with distributed "Smart Factories," the company argues it can deliver critical components faster, cheaper, and with less geopolitical risk.

In March 2026, the firm unveiled a new manufacturing platform specifically designed for aerospace and defense. The system is optimized for high-performance materials suited to demanding aerospace applications. This launch coincided with a funding round from Rule 1 Ventures, a U.S. venture capital firm focused on defense and national security technologies, signaling confidence in Roboze's role in resilient, AI-driven production for critical infrastructure.

For Italy, this represents a rare success story: a homegrown deep-tech company competing globally in sectors—aerospace, defense, and space—typically dominated by U.S. and multinational giants. The firm collaborates with both Italian and U.S. defense ministries, as well as strategic industrial partners in both countries.

The Lunar Ambition

Roboze's most audacious project involves printing on the Moon itself. In July 2022, the company's technology reached orbit, and it is now working with ESA on upcoming missions that could see its printers deployed on the lunar surface.

The concept is elegant: rather than transporting every component from Earth—an enormously expensive proposition—Roboze envisions using lunar materials to fabricate tools, habitat structures, and spare parts. This approach is seen as essential for sustainable, long-term human presence beyond Earth.

ESA has been researching lunar manufacturing techniques and is planning missions including the Artemis II mission—a crewed flyby of the Moon—which will rely on ESA's European Service Module. The agency is also developing advanced approaches for lunar 3D printing capabilities for future exploration missions.

Roboze is not alone in pursuing advanced manufacturing for space. Other firms are also developing high-temperature polymer and composite printers for aerospace and space applications, each seeking competitive advantages in this emerging sector.

Impact on Expats & Investors

For foreign professionals and investors tracking Italy's innovation ecosystem, Roboze offers a tangible case study in how regional talent and institutional support can scale to global relevance. The company's dual headquarters—R&D in Bari and production and sales in California—mirrors the hybrid model increasingly common among European deep-tech firms seeking to balance EU R&D subsidies with access to U.S. capital and defense contracts.

The firm's expansion and partnerships with global industrial leaders further illustrate how Italian mid-sized companies are embedding themselves in transatlantic supply chains, particularly in sectors deemed strategically critical by both the EU and NATO.

For those living in Italy, this translates into high-skill job creation in the Mezzogiorno—a region historically underserved by advanced manufacturing—and potential spinoff opportunities in materials science, robotics, and AI-driven quality control.

The Medical Frontier

Roboze's next frontier may prove just as transformative. The company has announced plans to enter the human prosthetics market, leveraging its expertise in biocompatible polymers, which are already used in spinal implants and orthopedic devices due to their mechanical strength, heat resistance, and chemical inertness.

The firm is collaborating with academic and medical institutions on developing advanced manufacturing capabilities for implantable medical devices. The goal: to make custom prosthetics and implants more accessible and affordable by eliminating the time and cost barriers inherent in traditional manufacturing.

This move places Roboze in competition with established medical device manufacturers, but the company's emphasis on precision, material innovation, and on-demand production could open new pathways for patient-specific treatments—particularly in Italy, where the public health system is under constant pressure to contain costs while improving outcomes.

The Competitive Landscape

Roboze's emphasis on industrial sovereignty and distributed manufacturing resonates in a geopolitical climate marked by supply chain fragility and strategic competition. The firm's ability to produce mission-critical components locally—whether for aerospace applications, industrial platforms, or other demanding sectors—reduces dependency on global logistics networks vulnerable to disruption.

Yet the company operates in a competitive market with other advanced manufacturing firms pursuing similar technologies and applications. Roboze's edge lies in its vertically integrated approach: it designs the printers, engineers the materials, and develops the software—all in-house. This gives the firm tighter quality control and the ability to customize solutions for clients with exacting requirements.

What Comes Next

As Roboze scales, it must navigate a complex regulatory landscape. Medical device certification in the EU requires meeting rigorous standards and securing appropriate regulatory approvals—a multi-year process. Space missions involve stringent qualification protocols, and defense contracts come with security clearances and export controls.

The company's ability to balance rapid innovation with regulatory compliance will determine whether it can translate its technological prowess into sustained commercial success. For now, Roboze remains a case study in how a mechanic's son from Bari turned a teenage hobby into a company that may soon be printing on the Moon—and inside the human body.